PTRH2 and cancer: Since the acquisition of anoikis resistance is an important determinant of neoplastic transformation and metastatic potential [1], [2], suppression of the Bit1 anoikis pathway in malignant cells may contribute to cancer progression, particularly in the acquisition of advanced tumorigenic and metastatic behaviour.